Research programme: serotonin 4 receptor agonists - Predix

Drug Profile

Research programme: serotonin 4 receptor agonists - Predix

Alternative Names: 5-HT4 receptor agonists - Predix

Latest Information Update: 21 Aug 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Predix Pharmaceuticals
  • Class
  • Mechanism of Action Serotonin 4 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Alzheimer's disease; Irritable bowel syndrome

Most Recent Events

  • 27 Mar 2006 No development reported - Preclinical for Alzheimer's disease in USA (unspecified route)
  • 27 Mar 2006 No development reported - Preclinical for Irritable bowel syndrome in USA (unspecified route)
  • 13 Feb 2004 Preclinical trials in Alzheimer's disease in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top